The sonographic appearance and obstetric management of placenta accreta by Chan, CP & Cheung, CSY
Title The sonographic appearance and obstetric management ofplacenta accreta
Author(s) Cheung, CSY; Chan, CP
Citation International Journal of Women's Health, 2012, v. 4, p. 587-594
Issued Date 2012
URL http://hdl.handle.net/10722/197657
Rights Creative Commons: Attribution 3.0 Hong Kong License
© 2012 Cheung and Chan, publisher and licensee Dove Medical Press Ltd. This is an Open Access 
article which permits unrestricted noncommercial use, provided the original work is properly cited.
International Journal of Women’s Health 2012:4 587–594
International Journal of Women’s Health
The sonographic appearance and obstetric 
management of placenta accreta
Charleen Sze-yan Cheung
Ben Chong-pun Chan
Department of Obstetrics and 
Gynaecology, Queen Mary Hospital, 
Hong Kong
Correspondence: Charleen Sze-yan Cheung 
Department of Obstetrics and 
Gynaecology, Queen Mary Hospital,  
102, Pokfulam Road, Hong Kong 
Tel +852 2255 4267 
Fax +852 2855 0947 
Email charleensycheung@hku.hk
Abstract: Placenta accreta is a condition of abnormal placental implantation in which the 
placental tissue invades beyond the decidua basalis. It may invade into or even through the 
myometrium and adjacent organs, such as the urinary bladder. The incidence has been rising in 
recent years. It is one of the important obstetric complications nowadays, leading to significant 
maternal morbidity and mortality. In the past, this condition was often diagnosed at the time of 
delivery when massive and unexpected hemorrhage occurred. Hysterectomy, associated with 
significant physical and psychological consequences, was usually the only management option. 
As more obstetricians have become aware of this condition, early identification with antenatal 
imaging diagnostic technology has become possible. Ultrasound scan plays an important role 
in the antenatal diagnosis. Various sonographic features with different specificity and sensitiv-
ity have been described in the literature. In equivocal cases, magnetic resonance imaging may 
be helpful. With such information, more accurate counseling can be offered to the mothers 
and their families before delivery. The delivery can also be arranged at a favorable time and in 
an institution where multidisciplinary support is available. Input from a hematologist, inter-
ventional radiologist, intensive care physician, urology surgeon, and/or other specialist are 
desirable. Apart from hysterectomy, various forms of conservative management can also be 
considered when the diagnosis is made prior to delivery. Fertility can therefore be preserved. 
After delivery, with or without hysterectomy performed, psychological support to the mothers 
and their families is essential.
Keywords: ultrasonography, hemorrhage, hysterectomy
Introduction
Morbidly adherent placenta represents a spectrum of disorders characterized by abnor-
mal adherence or penetration of the placenta into the uterine wall. Histologically, it 
has been defined according to the degree of pathological penetration. Placenta accreta 
refers to a superficial attachment without invasion into the myometrium. Placenta 
increta occurs when placental villi extend into the myometrium. In placenta percreta, 
the invasions extend deep beyond the uterine serosa. From a clinicosurgical point of 
view, different degrees of invasion may coexist in the same patient. The three types 
of abnormal placentation and their management are often collectively described in 
the literature.1,2
The vast majority of women with placenta accreta have an identifiable risk factor.3 
Placenta previa and previous cesarean delivery are the major risk factors for placenta 
accreta. The risk increases with the number of previous cesarean sections.4,5 Myometrial 
trauma and scarring resulting from repeated dilatation and curettage, or other corrective 
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surgeries also contribute to the risk of developing abnormal 
placental adherence. Advanced maternal age has also been 
identified as an independent risk factor. Others include smok-
ing, grand multiparity, and recurrent miscarriages.2,6–8
The incidence of placenta accreta has been escalating, 
from a reported occurrence of one in 30,000 deliveries in 
1950 to one in 2500 deliveries (a tenfold increase) in 1997.6,9 
This marked increase has been attributed to the increase in 
cesarean section rates worldwide.
Placenta accreta remains a leading cause of maternal hem-
orrhage and obstetric hysterectomy. Up to 38% of postpartum 
hysterectomies were found to be associated with placenta 
accreta in a review by the UK Obstetric Surveillance System.10 
Maternal morbidity and mortality are considerable. Related 
events and interventions include massive blood loss, dilutional 
or consumptive coagulopathy, blood transfusion, transfusion-
related reaction or acute injury, postpartum hysterectomy, 
cystotomy, intensive care, and prolonged hospitalization. 
Not only is there concern for the high demands on health 
resources and expenditure, concern about litigation for an 
adverse obstetric outcome is inevitable.8,10–13
A recent study has forecasted that a continued rise in 
Cesarean section rates could lead to substantial increase in 
incidence of placenta previa-accreta and maternal death.14
Identification of risk factors, accurate antenatal and 
preoperative diagnosis, multidisciplinary management, and 
appropriate counseling will all aid in the overall manage-
ment of women with placenta accreta and in reduction of 
maternal morbidity.
Ultrasonography
Ultrasonography remains a noninvasive, widely available 
and cost-effective modality of first-line diagnosis of placenta 
accreta in clinical practice.
Limitations to transabdominal ultrasound include the 
effect of maternal body habitus as well as its suboptimal 
visualization of the lower uterine cervix or area of placental 
invasion. The safety of transvaginal ultrasound in placenta 
previa has been accepted. It allows a closer view and more 
accurate examination of the lower uterine segment, lead-
ing to improved diagnostic accuracy in placenta previa-
accreta.15,16
Since the 1980s, numerous ultrasound imaging tech-
niques have been developed to assist in diagnosing morbidly 
adherent placenta antenatally. These include grayscale, 
color and/or three-dimensional power Doppler sonography. 
Various sonographic features and criteria for diagnosis have 
been suggested.
Retroplacental sonolucent zone
A normally occurring clear zone between the placenta and 
myometrium has been described.17 This area is observed from 
12 weeks and is believed to be associated with the dilated 
vessels of the decidua basalis. Deficiency and progressive 
loss of the decidua (Figure 1) has been proposed and con-
firmed histologically in placenta accreta.18 Obliteration of 
this sonolucent zone between the placenta and myometrium 
was first observed in the 1980s and confirmed in subsequent 
studies.19–21 However, the sensitivity of this sign in isolation 
remains low. A false positive rate of up to 50% has been 
reported.22
vascular lacunae
Multiple venous structures occurring throughout the myome-
trium and placenta in accreta were first described by Kerr de 
Mendonça in 1988.22 Subsequent observations of placental 
lakes were described as large and irregular (“Swiss cheese” 
appearance). These lacunae were not necessarily the areas of 
invasion. Presence of this sonographic sign has been reported 
to be associated with the highest positive predictive value for 
placenta accreta (Figure 2). When identified in the second 
and third trimesters, the sensitivity of this sign is 79%, with 
a positive predictive value of 92%.3,15,20,23 The presence of 
lacunae was also found to be significantly associated with 
risks of disseminated intravascular coagulopathy, massive 
transfusions, and intensive care.24
The presence of sonographic criteria is not pathogno-
monic and should be interpreted with caution in the clinical 
setting. Although found to be of high sensitivity and positive 
predictive value, the presence of placenta lacunae and lack 
of sonolucent zone have (not infrequently) been observed in 
placenta previa without morbid adherence of placenta.25
Figure 1 Deficiency of retroplacental sonolucent zone.
Note: Image courtesy of the Department of Diagnostic Radiology, Queen Mary 
Hospital, Hong Kong.
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Myometrial thinning
Progressive thinning of the retroplacental myometrium indi-
cates the proximity of placental tissue to the peritoneal serosa 
or surrounding viscera, particularly the bladder. Segmental 
myometrial thinning of ,1 mm is suggestive of an adher-
ent placenta (Figure 3). Combined with presence of large 
placental lacunae, the sensitivity of this sign reaches nearly 
100% and specificity is 72%–79%, with a positive predictive 
value of 73%.26,27
Interruption of bladder line
Lack of myometrial tissue could result in thinning or 
disruption of the vesicouterine interphase, which has 
been found to be associated with greater compromise 
(Figure 4). In reality, distinguishing between irregularities 
of the bladder wall and placenta accreta may sometimes 
be difficult.20,21
Presence of exophytic masses
In extreme cases, the presence of extrauterine placental paren-
chyma can confirm the diagnosis of placenta percreta.
The use of ultrasound greyscale has been shown to be 
capable of diagnosing placenta accreta with sensitivity rang-
ing from 87%–95%, specificity of 76%–98%, and a positive 
predictive value of 82%–93%.2,28 The predictive value of 
ultrasound in the diagnosis of placenta accreta in the first tri-
mester remains unclear.29 Table 1 summarizes the sonographic 
features of placenta accreta reported by various authors.
Color Doppler imaging
Color and power Doppler provide a higher specificity in the 
diagnosis of placenta accreta and in particular, the depth of 
invasion. A pattern of turbulent blood flow extending from 
the placenta into the surrounding tissues has been reported 
in placenta accreta.16 Other criteria include focal or diffuse 
Figure 2 vascular lacunae.
Note: Image courtesy of the Department of Diagnostic Radiology, Queen Mary 
Hospital, Hong Kong.
Figure 3 Myometrial thinning.
Note: Image courtesy of the Department of Diagnostic Radiology, Queen Mary 
Hospital, Hong Kong.
Figure 4 Interruption of bladder line.
Note: Image courtesy of the Department of Diagnostic Radiology, Queen Mary 
Hospital, Hong Kong.
Table 1 Summary of sonographic features of placenta accrete
Sonographic features of placenta 
accreta
Authors
Deficiency of retroplacental sonolucent 
zone
Pasto ME et al19
Hoffmann-Tretin JC et al18
Finberg HJ et al20
Hamanda S et al25
vascular lacunae Kerr de Mendonça L22
Oyelese Y et al15
Comstock CH et al20 
Yang JI et al24
Baughman WC et al23
Hamanda S et al25
Myometrial thinning Hudon L et al26
Twickler DM et al27
Interruption of bladder line Finberg HJ et al21
Comstock CH et al20
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intraparenchymal placental lacunar flow, vesicouterine serosa 
interphase hypervascularity, prominent retroplacental venous 
complex, and loss of retroplacental Doppler vascular signals.30 
The diagnostic sensitivity reached 82%, while positive predic-
tive value was 87% in one study looking at use of Doppler.31
Three-dimensional Doppler
Reported features include numerous coherent vessels involv-
ing the whole vesicouterine serosa interphase on basal view; 
and hypervascularity, inseparable cotyledonal and intervil-
lous circulations, chaotic branching, and detour vessels on 
lateral views.29,32
Magnetic resonance imaging (MRI)
Ultrasonography and MRI are comparable in diagnosing pla-
centa accreta. The latter has additional value in detecting depth 
of placental invasion and depicting posterior placenta accreta. 
However, there is insufficient evidence to support routine MRI 
scanning of patients with sonographically suspected placenta 
accreta to improve management and outcome. MRI is often 
recommended when ultrasound findings are inconclusive.29,33–36 
MRI findings suggestive of placenta accrete include uterine 
bulging, heterogeneous signal intensity within the placenta, 
dark intraplacental bands on T2-weighted images, tenting of 
the bladder, and direct visualization of placental invasion into 
pelvic structures.23 Figure 5 illustrates ultrasound examination 
with Doppler study showing a major anterior placenta previa 
accreta with bladder wall involvement. The MRI scan was also 
suggestive of deep myometrial invasion by placental tissue, 
but the bladder mucosa was intact.
Obstetric management strategies
Antenatal
Anticipation and identification of risk factors is essential in 
developing safe management strategies. It has been recom-
mended that women who had previous cesarean  section 
Figure 5 Ultrasound examination with Doppler study showing a major anterior placenta previa accreta with bladder wall involvement.
Notes: (A) and (B) -Transvaginal ultrasound scan images revealed no myometrial tissue between the lower uterine wall and the bladder. An abnormal vessel running within 
the bladder wall can also been seen (white arrows). (C) and (D) - Coronal and sagittal magnetic resonance images indicated a bulge at the bladder wall (black arrowheads). 
Image courtesy of the Department of Diagnostic Radiology, Queen Mary Hospital, Hong Kong.
Abbreviation: MRI, magnetic resonance imaging.
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should have placental localization to exclude placenta pre-
via and further investigation to identify placenta accreta, if 
necessary.37,38
The management of morbidly adherent placenta is a real 
obstetric challenge and should be undertaken by a consultant-
led multidisciplinary team in a tertiary care institute. Delivery 
is ideally planned and arranged electively under controlled 
conditions with appropriate surgical and hematological 
facilities.
The presence of a consultant obstetrician and anesthesi-
ologist at delivery, possible input from urology, gynecologic 
oncology, and vascular surgeons, blood products arrange-
ment and prompt delivery, and access to intensive care 
constitute a care bundle in managing a patient with placenta 
accreta.29,32,39
Optimal timing of a scheduled delivery depends on vari-
ous clinical factors. Elective preterm delivery is often neces-
sary because of pregnancy complications, like antepartum 
hemorrhage. The maternal benefits of earlier elective delivery 
must be balanced against the neonatal morbidity associated 
with premature birth. In the absence of antepartum hemor-
rhage or pregnancy complications, elective late-preterm 
delivery is acceptable to reduce the likelihood of emergency 
delivery at term.13,39
The adoption of conservative versus radical management 
is another important decision to be made in the planning 
process. Thorough preoperative counseling is crucial. The 
patient should be adequately counseled about the risks of 
catastrophic hemorrhage, blood transfusion, and visceral 
involvement. Possible interventions such as hysterectomy, 
ureteric stenting and cystotomy, or conservative measures 
(including leaving the placenta in situ, use of cell salvage, 
and interventional radiology) should also be discussed.
A preoperative checklist would be helpful in confirming 
necessary preparations and for identifying contact persons 
in case perioperative assistance is required.
Intrapartum
Anesthetic considerations include large-bore intravenous 
access, rapid replacement of fluid and blood, hemodynamic 
monitoring facilities, prevention of hypothermia, and throm-
boembolic prophylaxis.29,40
Dorsal lithotomy positioning with hip abduction but 
limited flexion can enable direct evaluation of intraopera-
tive vaginal bleeding, and allow uterine balloon placement 
if needed.
Immediate preoperative ultrasound mapping of the placen-
tal location aids in determining the optimal approach to the 
abdominal wall and uterine incisions. It is recommended that 
uterine incision be made away from the placenta during entry 
to the uterine cavity. Incision through the placenta and attempt 
to deliver the placenta often result in significant hemorrhage. 
Figure 6 illustrates a thin and very vascular uterine lower 
segment at the time of cesarean section. The rich vascularity 
usually correlates with the position of placentation. Attempt 
to remove the placenta leads to disruption of the infiltrated 
bed and is associated with increased maternal morbidity. It has 
been suggested that it may be sensible to complete the delivery 
of the infant and proceed to an intended hysterectomy with 
the placenta left in situ.13,29,38,41,42 A total rather than subtotal 
hysterectomy is advocated because of the risk of hemorrhage 
from lower-segment invasions. For the same reason, internal 
iliac artery ligation is associated with significant risk of fail-
ure in managing postpartum hemorrhage in placenta accreta 
because of the collateral arterial supplies. In cases where 
subtotal hysterectomy is performed, peritoneal closure over 
the cervical stump should be avoided as further hemorrhage 
may be concealed and unnoticed.3
Interventional radiology does play an important role in 
offering prophylactic measures to reduce uterine flow and 
prevent ongoing hemorrhage. Preoperative placement of a 
catheter in the internal iliac or uterine arteries, with or with-
out balloon inflation at the time of delivery, or embolization 
after cesarean section can be performed.39,43 Higher failure of 
embolization in placenta accreta was observed when com-
pared with its use for postpartum hemorrhage due to other 
causes, like uterine atony or retained products of gestation. 
A recent systematic review of uterus-preserving treatment 
modalities1 revealed that uterine artery embolization for 
placenta accreta could achieve a subsequent menstruation 
Figure 6 Thin and very vascular uterine lower segment at the time of cesarean 
section. 
Note: The rich vascularity usually correlates with the position of placentation.
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rate of 62% and pregnancy rate of 15%, and secondary hys-
terectomy rate of 18%. Most of the studies involved small 
numbers and we are still awaiting results from further larger 
prospective series.44,45
In selected groups of women, conservative management 
can be considered. The criteria for such an approach include 
the possibility of preoperative consultation, hemodynamic 
stability without significant blood loss, a wish to preserve 
fertility, and the availability of resources and expertise to 
follow up and manage late postpartum complications.45 
Conservative management aims to avoid hysterectomy 
by leaving the placenta in situ with or without additional 
measures, including arterial embolization, application of 
compression sutures, and segmental resection of the myo-
metrial tissues followed by repair of the defect or uterine 
reconstruction. Lack of comparative studies on the differ-
ent surgical techniques has resulted in wide variation in the 
approach adopted. Use of tissue sealants or even mesh has 
been reported, but to date, there is insufficient evidence on 
their effectiveness and safety.45–47
In a systematic review,1 expectant management in patients 
with invasive placentation is associated with a 67% rate of 
achieving subsequent pregnancy and a 19% rate of secondary 
hysterectomy at the same time.
Postpartum
Patients with placental accreta and especially those requir-
ing hysterectomy for postpartum hemorrhage are at risk for 
complications in relation to intrapartum hypotension and 
persistent coagulopathy. Collaboration with intensive care 
physicians and the monitoring of vital signs and organ func-
tions postoperatively is of paramount importance. Should 
there be hemodynamic instability or suspicion of hemo-
peritoneum, computed tomography (CT) or MRI should be 
undertaken and followed by exploratory laparotomy without 
delay. Persistent hematuria or anuria should alert clinicians 
of possible unrecognized urinary tract injury. Transient or 
permanent Sheehan syndrome is a known complication of 
massive postpartum hemorrhage. Hyponatremia may be an 
early sign for this.29
Secondary infection, sepsis, postpartum hemorrhage, 
and disseminated intravascular coagulopathy are the major 
clinical concerns after leaving the placenta in situ. Close 
surveillance and ready access to medical assessment and 
resuscitation are the key prerequisites to conservative 
management. Prophylactic broad-spectrum antibiotics and 
uterotonic agents are often recommended, although a consen-
sual guideline has yet to be established. Whether the placenta 
should be removed in the postpartum period or left to resorb 
or be expelled spontaneously remains controversial. Serum 
human chorionic gonadotropin and Doppler ultrasound may 
be utilized to assess the cessation of placental vascularity for 
consideration of interval removal, but the clinical correlation 
remains undetermined.48
Methotrexate has been proposed as a conservative 
measure for retained placenta with morbid adherence. 
Methotrexate, being a folate antagonist, is not without side 
effects and is contraindicated in breastfeeding. It is effective 
against proliferating trophoblasts, but its action on degenera-
tive placenta after delivery remains questionable and diverse 
in different series. In general, outcomes do not differ signifi-
cantly with or without use of methotrexate.49,50
Adequate support and assessment of psychological well-
being of the patient after major obstetric events are sometimes 
overlooked but indispensable. Debriefing sessions should be 
carried out with the patient and family at appropriate inter-
vals. Adequate explanation and effective communication 
helps to reduce the risk of medical litigation.
Conclusion
Placenta accreta has been evolving into a more common 
complication in modern obstetrics. The rising incidence is 
partly caused by our changing obstetric practice in terms of 
cesarean delivery rate, and it is one of the consequences we 
have to encounter from now onwards. The identification of 
high-risk group mothers, based on history, during the ante-
natal period is important and facilitates the diagnosis of this 
condition by imaging techniques, mainly ultrasonography. 
Various sonographic features have been reported and a 
combination of these features may sharpen the accuracy of 
the diagnosis. The diagnostic value of magnetic resonance 
imaging for placenta accreta remains controversial. When the 
antenatal diagnosis of placenta accreta has been made, the 
mothers should be under care of a consultant obstetrician-led 
team throughout and receive informative counseling prior to 
delivery. Elective cesarean delivery should be arranged in 
an institution with multidisciplinary support. Conservative 
management can be considered mainly for mothers with the 
wish to preserve fertility, although delayed hysterectomy in 
the postnatal period is still a possibility. For mothers with a 
completed family, a lower threshold for hysterectomy may 
be desirable. Close monitoring after the operation, prefer-
ably in an intensive care unit or high dependency unit, is of 
paramount importance. Psychological support to the mothers, 
especially those who had a hysterectomy performed, and 
their families is essential.
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